Bengaluru: Marking Rare Disease Day, Strand Life Sciences, A Subsidiya of Reliance Industries and A Leading Genomics Research Company, Has Launched The Strandomics Portal, Annovative Platform Diesigital Platform Desigital Platform Desigital Platform Desigital Assist doctors in diagnising rare diseases more efficiently.

The newly introduced portal provides clinicians with rapid and detailed Insights Into Gnetic Variants, Offering a Comprehensive and Account Assessment for Each PATENT.

This advancement is expected to enhance the Speed and Precision of Rare Disease Diagnoses, Ultimately Benefiting Patients Who Often Faces Prolonged Diagnostic Journeys.

AlongSide the launch of the strandomics portal, the company has announced a special initiative to offer genetic testing at a reduced cost for patients from economically weaker backgrounds, ENSURNDS, ENSURING THES Crucial diagnostic services are more widely accessible.

The Strandomics Portal is designed to Empower Healthcare Professionals. It offers Several Benefits, Such as Providing Quick and Clear Gnetic Insights to Aid in Faster Diagnosis, Allowing Independent Review of a Browader Set of Gentic Variants, and Improving Clynical Decision-Making Enhancing Prenatal Diagnosis and Specialist collaboration, Leading to Better Outcomes for Rare Genetic Conditions.

Speaking on the Occination, Dr Ramesh Hariharan, CEO and Co-Founder of Strand Life Sciences, Said, "We are dedicated to improve genetic diagnostics and ensuring accessibility for all. With the launch of the strandomics portal, we aim to empower doctors with better tools to combat rare diseases. We will continue to innovate and invest in advance gentic testing technologies."

Strand Life Sciences is a Pioneer in Genomic Diagnostics in India and a Trusted Name in the Field of Oncology, Rare Diseases, Women’s Health, and Infety Diseases.

Backed by a Strong Foundation in Biinformatics, Cutting-Edge Laboratory Research, and a Vast Hospital Partner Network, The Company IS Committed to Advanceing Genetic Diagnostics and Personalized Medicine.

It is also expanding into consumer genomics, providing individuals with personalized insights into their genetic profiles.

With the launch of the strandomics portal and the introduction of discounted genetic testing for underprivileged patients, Strand Life Sciences Continues Continues Its Morse the Gap In Rare Diagnosis and Treatment Accessibility in India.